子宮内圧カテーテルの世界市場：洞察、競合情勢、市場予測：2032年

子宮内圧カテーテルの市場規模は、2025年から2032年までの予測期間中にCAGR 6.53％で成長すると予測されています。早産や胎児苦痛などの状態を含む複雑な妊娠の発生率の上昇が、母体と胎児の最適な転帰を確保するための精密なモニタリングソリューションの需要を促進しています。同時に、発展途上地域における出生率の上昇が、子宮内圧カテーテルを含む高度ヘルスケア技術の必要性を拡大しています。さらに、胎児モニタリングの重要性に対する意識の高まりは、子宮収縮に関する正確でリアルタイムのデータの必要性を強調し、市場をさらに促進しています。さらに、主要市場参入企業による製品開発活動の急増は、カテーテル技術の革新的進歩につながり、機能性と魅力を高めています。これらの要因を総合すると、2025年から2032年までの予測期間中に、子宮内圧カテーテル市場を押し上げると予想されます。

子宮内圧カテーテル市場力学：

世界保健機関（WHO）が提供した最近のデータと統計（2023年）によると、世界中で推定1,340万人の赤ちゃんが早産で生まれています。早産は子宮収縮が不規則であったり不十分であったりすることが多く、母親と赤ちゃんの両方に合併症を引き起こす可能性があります。このような場合、子宮活動の正確なモニタリングは、陣痛の進行を評価し、適切な臨床介入を決定するために極めて重要です。IUPCは正確な子宮内圧をリアルタイムで測定できるため、医療従事者は子宮収縮の強さと頻度を注意深く監視することができます。これは、外部的な方法では効果が低い早産では特に重要であり、その結果、世界中のIUPC市場全体が拡大しています。

さらに、妊娠糖尿病は、過剰な胎児発育（macrosomia）を含む妊娠中および分娩中の合併症のリスクを増大させ、分娩の遷延や帝王切開などの介入の必要性につながる可能性があります。例えば、国際糖尿病連合が提供した最新のデータ（2025年）によると、2024年の妊娠糖尿病率は世界的にばらつきがあり、アフリカで約10.8％、欧州で13.9％、オーストラリアで14.9％、フランスで10.7％、インドで26.1％、スペインで37.6％、英国で23.1％と報告されています。このように、子宮収縮の正確なモニタリングは、妊娠糖尿病の女性の分娩管理において極めて重要です。なぜなら、分娩中に合併症が生じる可能性があり、タイムリーで的確な介入が必要となるからです。

さらに、新興国における出生率の上昇や胎児モニタリングに対する意識の高まりも、子宮内圧モニター市場を牽引する主な要因となっています。発展途上地域では、出生率の上昇により、妊産婦と新生児のヘルスケア・インフラの改善に重点が置かれています。これらの国では、増加する妊娠数を管理するために、より良い医療施設や技術に投資しているため、子宮内圧モニターのような高度なモニタリングソリューションの需要が増加しています。同時に、子宮機能不全や胎児苦痛のような合併症は、早期に発見されないと深刻な結果につながる可能性があるため、特に分娩中の胎児モニタリングの重要性に対する認識が高まっています。子宮内圧モニターは子宮収縮に関するリアルタイムで正確なデータを提供するため、医療従事者は合併症が発生したときに迅速に介入することができ、それによって世界中の子宮内圧カテーテル市場全体を押し上げています。

さらに、主要市場参入企業の存在が子宮内圧カテーテルの成長にさらに貢献しています。主要参入企業であるCooperSurgicalは、産科・婦人科機器市場の支配的な参入企業です。同社のIUPCであるIntran Plus（TM）やIntran Plus（TM）Disposable IUPCは、陣痛時の子宮内圧測定の正確さで知られています。同社の広範な病院ネットワーク、継続的な技術革新、産婦人科医療への注力は、産科病棟での製品採用を強力に推進し、世界の市場浸透を大きく後押ししています。

このように、上記の要因は、2025年から2032年までの予測期間中、子宮内圧カテーテルの市場全体を押し上げると予想されます。

しかし、感染や不快感のリスクや、子宮膜破裂、胎盤異常、特定の病状を持つ女性は子宮内圧カテーテル挿入の候補にならないなど、使用事例が限定されるため、これらが子宮内圧カテーテル市場成長の制限要因になる可能性があります。

子宮内圧カテーテル市場セグメント分析：

子宮内圧カテーテル市場の製品セグメントでは、2024年にはトランスデューサチップカテーテルカテゴリーが最大のシェアを占めると予想されています。トランスデューサチップカテーテルは、その高度な技術と子宮収縮をモニタリングする精度の向上により、子宮内圧カテーテル（IUPC）市場全体を押し上げる重要な役割を果たしています。トランスデューサーチップカテーテルは、カテーテル先端にセンサーを内蔵しており、子宮内圧を直接測定できます。この技術により、液体を使用するシステムの精度を妨げる気泡やその他の問題のリスクが排除され、子宮活動に関するより信頼性の高いデータが得られます。トランスデューサチップカテーテルが提供するリアルタイムの正確な測定値は、ヘルスケアプロバイダーが陣痛の進行をモニターし、合併症を早期に発見し、十分な情報に基づいた臨床判断を下す能力を向上させる。さらに、これらのカテーテルの使いやすさと性能の向上は、医療従事者にとってより魅力的なものとなり、病院や分娩センターでの採用拡大につながっています。

ヘルスケア施設が患者の安全性と転帰の正確性を優先し続ける中、トランスデューサチップIUPCの需要は高まり、IUPC市場全体の成長に寄与しています。正確なデータが重要なハイリスク妊娠において優れたモニタリング能力を提供するその能力は、市場拡大を促進する役割をさらに確固たるものにしています。例えば、Clinical Innovations（Laborieブランド）のKoala（R）子宮内圧カテーテルは、測定誤差のリスクを最小限に抑えて正確な子宮内圧測定値を提供するトランスデューサチップカテーテルの顕著な例です。同様に、MedtronicのINTRAN（TM）Plus Disposable IUPCは、挿入を簡略化し、内部トランスデューサチップにより信頼性の高い測定値を提供するように設計されています。これらの技術革新は、臨床医の作業負担を軽減し、患者の安全性を向上させ、インターベンション関連の合併症を減らすという病院の目標に沿うものです。

したがって、上記のすべての要因は、予測期間中に世界の子宮内圧カテーテル市場の全体的な成長を後押しするセグメントにとってかなりの収益を生み出すと予想されます。

すべての地域の中で、北米は2024年に世界の子宮内圧カテーテル市場で最大のシェアを占めると予想されます。子宮内圧カテーテル市場の主な促進要因は、早産の有病率の上昇、妊娠中の合併症の増加、分娩時の母子の安全性に関する人々の意識の高まり、新製品や先進的な製品に対する需要の高まり、低侵襲手術の採用の増加、同地域で戦略的活動に従事する主要企業の存在などです。

米国疾病予防管理センター（CDC）が提供したデータ（2024年）によると、2022年の米国の出生率は人口1,000人当たり11人、出生率は15～44歳の女性1,000人当たり56.3人でした。出生率が高いということは、分娩遷延、子宮機能不全、胎児発育不全などの合併症を避けるために慎重な監視を必要とする妊娠が多いことを意味します。ヘルスケアプロバイダーが妊産婦と新生児の転帰を改善しようと努力するにつれて、彼らはますますIUPCを採用し、より良いコントロールと出産中の管理を確保するようになり、それによって子宮内圧カテーテルの市場は、地域全体で後押しすることが期待されています。

さらに、疾病予防管理センター（Centre for Disease Control and Prevention）が提供した最近のデータ（2023年）によると、妊娠中に糖尿病（妊娠糖尿病）の診断を受けた出産する母親の割合は、2021年には6.0％から8.3％に増加しました。IUPCは子宮内圧の正確なリアルタイムデータを提供するため、ヘルスケア提供者は異常を察知して迅速に対応することができます。妊娠糖尿病の症例が世界的に増加し、特に妊産婦の年齢や肥満の増加に伴い、IUPCのような高度なモニタリング・ソリューションへの需要が高まり、市場拡大の原動力になると予想されます。

さらに、同地域における女性人口の増加は、子宮内圧カテーテルの需要を促進します。例えば、世界保健機関（WHO）が発表した最新データ（2022年）によると、米国における妊産婦死亡の約半数は、意識の向上と妊婦が質の高いケアにアクセスできる限り、予防が可能です。また、最大5万人の女性が妊娠中、出産時、産後に重度の合併症を経験する可能性があります。これらの統計は、妊産婦モニタリングの改善と質の高い産科医療の緊急の必要性を強調しており、子宮内圧カテーテル（IUPC）の需要の高まりを直接的に裏付けています。米国における妊産婦死亡の半分が予防可能であるという事実は、IUPCが子宮収縮に関するリアルタイムのデータを提供し、子宮破裂や不十分な分娩進行などの合併症の予防に役立つことによって大きな影響を与えることができる領域において、タイムリーで正確な分娩モニタリングの重要な役割を強調しています。

したがって、上記のすべての要因の相互作用により、北米の予測期間中、同地域の子宮内圧カテーテル市場は拡大すると予想されます。

子宮内圧カテーテル市場の主要企業：

子宮内圧カテーテル市場で事業を展開している主要な市場参入企業には、Cardinal Health、Koninklijke Philips N.V.、Utah Medical Products, Inc.、CooperSurgical Inc.、Thomas Medical、VYAIRE、Laborie、LABOTECT GMBH、Kentec Medical, Inc.、General Electric Company、Famasys Inc.、MicroPort Scientific Corporationなどがあります。

子宮内圧カテーテル市場における最近の開発活動：

• 2022年12月、女性の生殖の健康に焦点を当てたバイオメディカル企業であるFamasys Inc.は、選択的卵管評価のための最初のFDA認可子宮内カテーテルである製品FemCath（TM）が市販されたと発表しました。
• 2021年4月、MicroPort Scientific Corporationの子会社であるShanghai Horizon Medical Technology Co.Ltd.の製品である子宮内人工授精カテーテルOrkid（R）が上海市薬品監督管理局から登録証を取得したと発表しました。

子宮内避妊カテーテル市場調査報告書の主なポイント

• 現在の子宮内圧カテーテルの市場規模分析（2024年）、8年間（2025年～2032年）の市場予測
• 過去3年間に起こった主な製品/技術開発、合併、買収、提携、合弁事業
• 子宮内圧カテーテル市場を独占する主要企業
• 子宮内圧カテーテル市場の競合他社が利用できる様々な機会
• 2024年に上位を占めるセグメントと2032年におけるこれらのセグメントの業績
• 現在の子宮内圧カテーテル市場のシナリオにおいて、上位の業績を上げている地域と国
• 今後、企業が子宮内圧カテーテル市場の成長機会に集中すべき地域と国

子宮内圧カテーテル市場のよくある質問

1.子宮内圧カテーテル

• 子宮内圧カテーテル（IUPC）は、陣痛中の子宮収縮をモニターするために妊婦の子宮内に留置される装置です。カテーテルは陣痛中の羊膜腔内の圧力を測定し、医師は陣痛の強さ、頻度、持続時間を評価することができます。

2.子宮内圧カテーテル市場

• 子宮内圧カテーテル市場は、2025年から2032年までの予測期間中にCAGR 6.53％で成長すると予測されています。

3.子宮内圧カテーテル市場の促進要因

• 早産や胎児苦痛などの状態を含む複雑な妊娠の発生率が上昇しているため、母体と胎児の転帰を最適なものにするための精密なモニタリング・ソリューションに対する需要が高まっています。同時に、発展途上地域における出生率の上昇は、これらの地域が医療インフラを強化するにつれて、IUPCを含む高度ヘルスケア技術の必要性を拡大しています。胎児モニタリングの重要性に対する意識の高まりは、子宮収縮に関する正確でリアルタイムのデータの必要性を強調し、市場をさらに促進しています。さらに、主要市場参入企業別製品開発活動の急増は、カテーテル技術の革新的な進歩につながり、機能性と魅力を高めています。これらの要因を総合すると、2025年から2032年までの予測期間中、IUPCsの市場を押し上げると予想されます。

4.子宮内圧カテーテル市場で事業を展開する主要企業

• 子宮内圧カテーテル市場で事業を展開している主な市場参入企業には、Cardinal Health、Koninklijke Philips N.V.、Utah Medical Products, Inc.、CooperSurgical Inc.、Thomas Medical、VYAIRE、Laborie、LABOTECT GMBH、Kentec Medical, Inc.、General Electric Company、Femapys Inc.、MicroPort Scientific Corporationなどがあります。

5.子宮内圧カテーテル市場で最もシェアが高い地域

• すべての地域の中で、北米が2024年に世界の子宮内圧カテーテル市場で最大のシェアを占めると予想されています。子宮内圧カテーテル市場の主な促進要因は、早産の有病率の上昇、妊娠中の合併症の増加、分娩時の母子の安全性に関する人々の意識の高まり、新製品・先端製品に対する需要の高まり、低侵襲手技の採用の増加、同地域で戦略的活動に従事する主要企業の存在などです。

目次

第1章 子宮内圧カテーテル市場レポートのイントロダクション

第2章 子宮内圧カテーテル市場のエグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 子宮内圧カテーテル市場の主な要因分析

• 子宮内圧カテーテル市場促進要因
  • 合併症妊娠の増加
  • 発展途上地域における出生率の上昇
  • 胎児モニタリングへの意識の高まり
  • 世界中の主要な市場参入企業別製品開発活動の増加
• 子宮内圧カテーテル市場抑制要因と課題
  • 感染や不快感のリスク
  • 破水、胎盤異常、または特定の病状を持つ女性など、特定のケースでは使用が制限される
• 子宮内圧カテーテル市場の機会
  • カテーテル技術の改良により、子宮内圧カテーテルはより安全になり、より日常的な症例に適用できるようになっている

第6章 子宮内圧カテーテル市場：ポーターのファイブフォース分析

第7章 子宮内圧カテーテル市場評価

• 製品別
  • 液体充填カテーテル
  • トランスデューサーチップカテーテル
• エンドユーザー別
  • 病院
  • 外来手術センター（ASC）
  • 専門クリニック
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 子宮内圧カテーテル市場の企業と製品プロファイル

• Cardinal Health
• Koninklijke Philips N.V.
• Utah Medical Products, Inc.
• CooperSurgical Inc.
• Thomas Medical
• VYAIRE
• Laborie
• LABOTECT GMBH
• Kentec Medical, Inc.
• General Electric Company
• Femasys Inc.
• MicroPort Scientific Corporation

第9章 KOLの見解

第10章 プロジェクトアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Intrauterine Pressure Catheters Market in Global (2022-2032)
• Table 3: Intrauterine Pressure Catheters Market in Global by Product (2022-2032)
• Table 4: Intrauterine Pressure Catheters Market in Global by End-User (2022-2032)
• Table 5: Intrauterine Pressure Catheters Market in Global by Geography (2022-2032)
• Table 6: Intrauterine Pressure Catheters Market in North America (2022-2032)
• Table 7: Intrauterine Pressure Catheters Market in the United States (2022-2032)
• Table 8: Intrauterine Pressure Catheters Market in Canada (2022-2032)
• Table 9: Intrauterine Pressure Catheters Market in Mexico (2022-2032)
• Table 10: Intrauterine Pressure Catheters Market in Europe (2022-2032)
• Table 11: Intrauterine Pressure Catheters Market in France (2022-2032)
• Table 12: Intrauterine Pressure Catheters Market in Germany (2022-2032)
• Table 13: Intrauterine Pressure Catheters Market in United Kingdom (2022-2032)
• Table 14: Intrauterine Pressure Catheters Market in Italy (2022-2032)
• Table 15: Intrauterine Pressure Catheters Market in Spain (2022-2032)
• Table 16: Intrauterine Pressure Catheters Market in the Rest of Europe (2022-2032)
• Table 17: Intrauterine Pressure Catheters Market in Asia-Pacific (2022-2032)
• Table 18: Intrauterine Pressure Catheters Market in China (2022-2032)
• Table 19: Intrauterine Pressure Catheters Market in Japan (2022-2032)
• Table 20: Intrauterine Pressure Catheters Market in India (2022-2032)
• Table 21: Intrauterine Pressure Catheters Market in Australia (2022-2032)
• Table 22: Intrauterine Pressure Catheters Market in South Korea (2022-2032)
• Table 23: Intrauterine Pressure Catheters Market in Rest of Asia-Pacific (2022-2032)
• Table 24: Intrauterine Pressure Catheters Market in the Rest of the World (2022-2032)
• Table 25: Intrauterine Pressure Catheters Market in the Middle East (2022-2032)
• Table 26: Intrauterine Pressure Catheters Market in Africa (2022-2032)
• Table 27: Intrauterine Pressure Catheters Market in South America (2022-2032)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Intrauterine Pressure Catheters Market in Global (2022-2032)
• Figure 3: Intrauterine Pressure Catheters Market in Global by Product (2022-2032)
• Figure 4: Intrauterine Pressure Catheters Market in Global by End-User (2022-2032)
• Figure 5: Intrauterine Pressure Catheters Market in Global by Geography (2022-2032)
• Figure 6: Intrauterine Pressure Catheters Market in North America (2022-2032)
• Figure 7: Intrauterine Pressure Catheters Market in the United States (2022-2032)
• Figure 8: Intrauterine Pressure Catheters Market in Canada (2022-2032)
• Figure 9: Intrauterine Pressure Catheters Market in Mexico (2022-2032)
• Figure 10: Intrauterine Pressure Catheters Market in Europe (2022-2032)
• Figure 11: Intrauterine Pressure Catheters Market in France (2022-2032)
• Figure 12: Intrauterine Pressure Catheters Market in Germany (2022-2032)
• Figure 13: Intrauterine Pressure Catheters Market in United Kingdom (2022-2032)
• Figure 14: Intrauterine Pressure Catheters Market in Italy (2022-2032)
• Figure 15: Intrauterine Pressure Catheters Market in Spain (2022-2032)
• Figure 16: Intrauterine Pressure Catheters Market in the Rest of Europe (2022-2032)
• Figure 17: Intrauterine Pressure Catheters Market in Asia-Pacific (2022-2032)
• Figure 18: Intrauterine Pressure Catheters Market in China (2022-2032)
• Figure 19: Intrauterine Pressure Catheters Market in Japan (2022-2032)
• Figure 20: Intrauterine Pressure Catheters Market in India (2022-2032)
• Figure 21: Intrauterine Pressure Catheters Market in Australia (2022-2032)
• Figure 22: Intrauterine Pressure Catheters Market in South Korea (2022-2032)
• Figure 23: Intrauterine Pressure Catheters Market in Rest of Asia-Pacific (2022-2032)
• Figure 24: Intrauterine Pressure Catheters Market in the Rest of the World (2022-2032)
• Figure 25: Intrauterine Pressure Catheters Market in the Middle East (2022-2032)
• Figure 26: Intrauterine Pressure Catheters Market in Africa (2022-2032)
• Figure 27: Intrauterine Pressure Catheters Market in South America (2022-2032)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Market Opportunities
• Figure 31: PORTER'S Five Force Analysis

Intrauterine Pressure Catheters (IUPCs) Market by Product (Fluid-Filled Catheters and Transducer Tip Catheters), End-User (Hospitals, Ambulatory Surgical Centers (ASCS), and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising incidence of complicated pregnancies, rising birth rates in developing regions, growing awareness of fetal monitoring, and increase in product development activities by key market players across the globe.

The intrauterine pressure catheters market is estimated to grow at a CAGR of 6.53% during the forecast period from 2025 to 2032. The rising incidence of complicated pregnancies, including conditions like preterm labor and fetal distress, drives the demand for precise monitoring solutions to ensure optimal maternal and fetal outcomes. Concurrently, increasing birth rates in developing regions are expanding the need for advanced healthcare technologies, including intrauterine pressure catheters. Additionally, the growing awareness of the importance of fetal monitoring underscores the necessity for accurate and real-time data on uterine contractions, further propelling the market. Furthermore, the surge in product development activities by key market players is leading to innovative advancements in catheter technology, which enhances their functionality and appeal. Collectively, these factors are expected to boost the market for intrauterine pressure catheters during the forecast period from 2025 to 2032.

Intrauterine Pressure Catheters Market Dynamics:

According to the recent data and stats provided by the World Health Organization (2023), an estimated 13.4 million babies were born preterm across the globe. Preterm labor often involves irregular or insufficient uterine contractions, which can lead to complications for both the mother and the baby. In such cases, precise monitoring of uterine activity is crucial to assess labor progression and determine the appropriate clinical interventions. IUPCs provide accurate, real-time measurement of intrauterine pressure, allowing healthcare providers to closely monitor the strength and frequency of contractions, which is particularly important in preterm labor where external methods may be less effective thereby escalating the overall market of IUPCs across the globe.

Furthermore, gestational diabetes increases the risk of complications during pregnancy and labor, including excessive fetal growth (macrosomia), which can lead to prolonged labor or the need for interventions such as C-sections. For instance, as per the latest data provided by the International Diabetes Federation (2025), in 2024 gestational diabetes mellitus rates varied globally, with approximately 10.8% reported in Africa, 13.9% in Europe, 14.9% in Australia, 10.7% in France, 26.1% in India, 37.6% in Spain, and 23.1% in the United Kingdom. Thus, accurate monitoring of uterine contractions becomes crucial in managing labor for women with gestational diabetes, as complications can arise during delivery that require timely and precise interventions.

Furthermore, the rising birth rates in developing regions and growing awareness of fetal monitoring are other key factors collectively driving the market for intrauterine pressure monitors. In developing regions, increasing birth rates are putting more focus on improving maternal and neonatal healthcare infrastructure. As these countries invest in better medical facilities and technologies to manage the growing number of pregnancies, the demand for advanced monitoring solutions, like intrauterine pressure monitors, is on the rise. At the same time, there is a heightened awareness of the importance of fetal monitoring, especially during labor, as complications like uterine dysfunction and fetal distress can lead to severe outcomes if not detected early. Intrauterine pressure monitors provide real-time, accurate data on uterine contractions, enabling healthcare providers to intervene swiftly when complications arise thereby boosting the overall market of intrauterine pressure catheters across the globe.

Additionally, the presence of key market players is further contributing to the growth of intrauterine pressure catheters. Major player CooperSurgical which is a dominant player in the obstetrics and gynecology device market. Their IUPCs such as Intran Plus(TM), and Intran Plus(TM) Disposable IUPC are known for accuracy in intrauterine pressure measurement during labor. The company's broad hospital network, continuous innovation, and OB-GYN focus drive strong product adoption in maternity wards, significantly boosting market penetration worldwide.

Thus, the factors mentioned above are expected to boost the overall market of intrauterine pressure catheters during the forecast period from 2025 to 2032.

However, the risk of infection and discomfort and limited use in certain cases such as women with ruptured membranes, placental abnormalities, or certain medical conditions may not be candidates for IUPC insertion thus, these may be the limiting factors for the intrauterine pressure catheters market growth.

Intrauterine Pressure Catheters Market Segment Analysis:

Intrauterine Pressure Catheters (IUPCs) Market by Product (Fluid-Filled Catheters and Transducer Tip Catheters), End-User (Hospitals, Ambulatory Surgical Centers (ASCS), and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the intrauterine pressure catheters market, the transducer tip catheters category is expected to hold the largest share in the year 2024. Transducer tip catheters are playing a significant role in boosting the overall market of intrauterine pressure catheters (IUPCs) due to their advanced technology and enhanced accuracy in monitoring uterine contractions. Transducer tip catheters feature a built-in sensor at the catheter's tip, which allows for direct measurement of intrauterine pressure. This technology eliminates the risk of air bubbles and other issues that can interfere with the accuracy of fluid-based systems, providing more reliable data on uterine activity. The real-time, precise readings offered by transducer tip catheters improve the ability of healthcare providers to monitor labor progression, detect complications early, and make informed clinical decisions. Additionally, the ease of use and improved performance of these catheters have made them more appealing to medical professionals, leading to increased adoption in hospitals and birthing centers.

As healthcare facilities continue to prioritize patient safety and outcome accuracy, the demand for transducer tip IUPCs is rising, contributing to the overall growth of the IUPC market. Their ability to offer superior monitoring capabilities in high-risk pregnancies, where accurate data is crucial, further solidifies their role in driving market expansion. For instance, Koala(R) Intrauterine Pressure Catheter by Clinical Innovations (a Laborie brand) is a prominent example of a transducer tip catheter that offers accurate uterine pressure readings with minimal risk of measurement error. Similarly, the INTRAN(TM) Plus Disposable IUPC by Medtronic is designed to simplify insertion and deliver reliable readings with an internal transducer tip. These innovations help reduce clinician workload, improve patient safety, and align with hospital goals of reducing intervention-related complications.

Hence, all the above-mentioned factors are expected to generate considerable revenue for the segment pushing the overall growth of the global intrauterine pressure catheters market during the forecast period.

North America is expected to dominate the overall intrauterine pressure catheters market:

Among all the regions, North America is expected to hold the largest share of the global intrauterine pressure catheters market in 2024. The key driving factors of the intrauterine pressure catheters market are the increasing prevalence of preterm birth, increasing complications in pregnancies, increasing awareness among the people about the safety of mother and child during the delivery, growing demand for new and advanced products, increased adoption of minimally invasive procedure, and the presence of key players engaged in strategic activities in the region.

According to the data provided by the Centers for Disease Control and Prevention (CDC) (2024), in 2022, the birth rate was 11 per 1000 people and the fertility rate was 56.3 births per 1000 women aged between 15-44 in the United States. Higher birth rates mean more pregnancies that may require careful monitoring to avoid complications such as prolonged labor, uterine dysfunction, or fetal distress. As healthcare providers strive to improve maternal and neonatal outcomes, they increasingly adopt IUPCs to ensure better control and management during childbirth thereby the market of intrauterine pressure catheters is expected to boost across the region.

Additionally, as per the recent data provided by the Centre for Disease Control and Prevention (2023), the percentage of mothers giving birth who received a diagnosis of diabetes during pregnancy (gestational diabetes) increased from 6.0% to 8.3% in 2021. IUPCs provide accurate, real-time data on uterine pressure, allowing healthcare providers to detect any irregularities and respond promptly. As gestational diabetes cases rise globally, especially with increasing maternal age and obesity, the demand for advanced monitoring solutions like IUPCs is expected to grow, driving market expansion.

Furthermore, the growing female population in the region will in turn propel the demand for intrauterine pressure catheters. For instance, according to the latest data presented by the World Health Organization (WHO) (2022), about half of maternal deaths in the United States were preventable, so long as there's increased awareness and pregnant women can get access to quality care. Also, Up to 50,000 women may experience severe complications during pregnancy, at delivery, or in the postpartum period. These statistics highlight the urgent need for improved maternal monitoring and quality obstetric care, directly supporting the growing demand for intrauterine pressure catheters (IUPCs). The fact that half of maternal deaths in the U.S. are preventable underscores the critical role of timely and accurate labor monitoring in an area where IUPCs can make a substantial impact by providing real-time data on uterine contractions, helping to prevent complications such as uterine rupture or inadequate labor progression.

Hence, the interplay of all the above-mentioned factors is anticipated to augment the market for intrauterine pressure catheters in the region during the forecasted period in North America.

Intrauterine Pressure Catheters Market Key Players:

Some of the key market players operating in the intrauterine pressure catheters market include Cardinal Health, Koninklijke Philips N.V., Utah Medical Products, Inc., CooperSurgical Inc., Thomas Medical, VYAIRE, Laborie, LABOTECT GMBH, Kentec Medical, Inc., General Electric Company, Femasys Inc., MicroPort Scientific Corporation, and others.

Recent Developmental Activities in the Intrauterine Pressure Catheters Market:

• In December 2022, Femasys Inc., a biomedical company focused on women's reproductive health, announced that its product FemCath(TM), the first FDA-cleared intrauterine catheter for selective tubal evaluation, became commercially available.
• In April 2021, MicroPort Scientific Corporation announced Orkid(R) intrauterine insemination catheter, a product by Shanghai Horizon Medical Technology Co., Ltd., a subsidiary of MicroPort Scientific Corporation, received the registration certificate from the Shanghai Municipal Drug Administration.

Key takeaways from the intrauterine pressure catheters market report study:

• Market size analysis for current intrauterine pressure catheters size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the intrauterine pressure catheters market.
• Various opportunities available for the other competitors in the intrauterine pressure catheters market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current intrauterine pressure catheters market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for intrauterine pressure catheter market growth in the coming future?

Target audience who can benefit from this intrauterine pressure catheters market report study:

• Intrauterine pressure catheter product providers
• Research organizations and consulting companies
• Intrauterine pressure catheters-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in intrauterine pressure catheters
• Various end-users who want to know more about the intrauterine pressure catheters market and the latest technological developments in the intrauterine pressure catheters market.

Frequently Asked Questions for the Intrauterine Pressure Catheters Market:

1. What are intrauterine pressure catheters?

• An intrauterine pressure catheter (IUPC) is a device placed inside a pregnant woman's uterus to monitor uterine contractions during labor. The catheter measures the pressure within the amniotic space during contractions and allows physicians to evaluate the strength, frequency, and duration of contractions.

2. What is the market for intrauterine pressure catheters?

• The intrauterine pressure catheters market is estimated to grow at a CAGR of 6.53% during the forecast period from 2025 to 2032.

3. What are the drivers for the intrauterine pressure catheter market?

• The rising incidence of complicated pregnancies, including conditions like preterm labor and fetal distress, drives the demand for precise monitoring solutions to ensure optimal maternal and fetal outcomes. Concurrently, increasing birth rates in developing regions are expanding the need for advanced healthcare technologies, including IUPCs, as these areas enhance their medical infrastructure. Growing awareness of the importance of fetal monitoring underscores the necessity for accurate and real-time data on uterine contractions, further propelling the market. Additionally, the surge in product development activities by key market players is leading to innovative advancements in catheter technology, which enhances their functionality and appeal. Collectively, these factors are expected to boost the market for IUPCs during the forecast period from 2025 to 2032.

4. Who are the key players operating in the intrauterine pressure catheter market?

• Some of the key market players operating in the intrauterine pressure catheters market include Cardinal Health, Koninklijke Philips N.V., Utah Medical Products, Inc., CooperSurgical Inc., Thomas Medical, VYAIRE, Laborie, LABOTECT GMBH, Kentec Medical, Inc., General Electric Company, Femasys Inc., MicroPort Scientific Corporation, and others.

5. Which region has the highest share in the intrauterine pressure catheters market?

• Among all the regions, North America is expected to hold the largest share of the global intrauterine pressure catheters market in 2024. The key driving factors of the intrauterine pressure catheters market are the increasing prevalence of preterm birth, increasing complications in pregnancies, increasing awareness among the people about the safety of mother and child during the delivery, growing demand for new and advanced products, increased adoption of minimally invasive procedure, and the presence of key players engaged in strategic activities in the region.

Table of Contents

1. Intrauterine Pressure Catheters Market Report Introduction

• 1.1 Scope of the Study
• 1.2 Market Segmentation
• 1.3 Market Assumption

2. Intrauterine Pressure Catheters Market Executive Summary

• 2.1 Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1 The United States
• 4.2 Europe
• 4.3 Japan
• 4.4 China

5. Intrauterine Pressure Catheters Market Key Factors Analysis

• 5.1. Intrauterine Pressure Catheters Market Drivers
  • 5.1.1 The rising incidence of complicated pregnancies
  • 5.1.2 Rising birth rates in developing regions
  • 5.1.3 Growing awareness of fetal monitoring
  • 5.1.4 Increase in product development activities by key market players across the globe.
• 5.2 Intrauterine Pressure Catheters Market Restraints and Challenges
  • 5.2.1 Risk of infection and discomfort
  • 5.2.2 Limited use in certain cases such as women with ruptured membranes, placental abnormalities, or certain medical conditions
• 5.3 Intrauterine Pressure Catheters Market Opportunities
  • 5.3.1 Undergoing improvements in catheter technology are making intrauterine pressure catheters safer and applicable to more routine cases

6. Intrauterine Pressure Catheters Market Porter's Five Forces Analysis

• 6.1 Bargaining Power of Suppliers
• 6.2 Bargaining Power of Consumers
• 6.3 Threat of New Entrants
• 6.4 Threat of Substitutes
• 6.5 Competitive Rivalry

7. Intrauterine Pressure Catheters Market Assessment

• 7.1 By Product
  • 7.1.1 Fluid-Filled Catheters
  • 7.1.2 Transducer Tip Catheters
• 7.2 By End-User
  • 7.2.1 Hospitals
  • 7.2.2 Ambulatory Surgical Centers (ASCs)
  • 7.2.3 Specialty Clinics
• 7.3 By Geography
  • 7.3.1 North America
    • 7.3.1.1 United States Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
    • 7.3.1.2 Canada Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
    • 7.3.1.3 Mexico Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
  • 7.3.2 Europe
    • 7.3.2.1 France Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
    • 7.3.2.2 Germany Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
    • 7.3.2.3 United Kingdom Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
    • 7.3.2.4 Italy Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
    • 7.3.2.5 Spain Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
    • 7.3.2.6 Rest of Europe Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 China Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
    • 7.3.3.2 Japan Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
    • 7.3.3.3 India Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
    • 7.3.3.4 Australia Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
    • 7.3.3.5 South Korea Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
    • 7.3.3.6 Rest of Asia-Pacific Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
  • 7.3.4 Rest of the World (RoW)
    • 7.3.4.1 Middle East Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
    • 7.3.4.2 Africa Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)
    • 7.3.4.3 South America Intrauterine Pressure Catheters Market Size in USD Million (2022-2032)

8. Intrauterine Pressure Catheters Market Company and Product Profiles

• 8.1 Cardinal Health
  • 8.1.1 Company Overview
  • 8.1.2 Company Snapshot
  • 8.1.3 Financial Overview
  • 8.1.4 Product Listing
  • 8.1.5 Entropy
• 8.2 Koninklijke Philips N.V.
  • 8.2.1 Company Overview
  • 8.2.2 Company Snapshot
  • 8.2.3 Financial Overview
  • 8.2.4 Product Listing
  • 8.2.5 Entropy
• 8.3 Utah Medical Products, Inc.
  • 8.3.1 Company Overview
  • 8.3.2 Company Snapshot
  • 8.3.3 Financial Overview
  • 8.3.4 Product Listing
  • 8.3.5 Entropy
• 8.4 CooperSurgical Inc.
  • 8.4.1 Company Overview
  • 8.4.2 Company Snapshot
  • 8.4.3 Financial Overview
  • 8.4.4 Product Listing
  • 8.4.5 Entropy
• 8.5 Thomas Medical
  • 8.5.1 Company Overview
  • 8.5.2 Company Snapshot
  • 8.5.3 Financial Overview
  • 8.5.4 Product Listing
  • 8.5.5 Entropy
• 8.6 VYAIRE
  • 8.6.1 Company Overview
  • 8.6.2 Company Snapshot
  • 8.6.3 Financial Overview
  • 8.6.4 Product Listing
  • 8.6.5 Entropy
• 8.7 Laborie
  • 8.7.1 Company Overview
  • 8.7.2 Company Snapshot
  • 8.7.3 Financial Overview
  • 8.7.4 Product Listing
  • 8.7.5 Entropy
• 8.8 LABOTECT GMBH
  • 8.8.1 Company Overview
  • 8.8.2 Company Snapshot
  • 8.8.3 Financial Overview
  • 8.8.4 Product Listing
  • 8.8.5 Entropy
• 8.9 Kentec Medical, Inc.
  • 8.9.1 Company Overview
  • 8.9.2 Company Snapshot
  • 8.9.3 Financial Overview
  • 8.9.4 Product Listing
  • 8.9.5 Entropy
• 8.10. General Electric Company
  • 8.10.1 Company Overview
  • 8.10.2 Company Snapshot
  • 8.10.3 Financial Overview
  • 8.10.4 Product Listing
  • 8.10.5 Entropy
• 8.11. Femasys Inc.
  • 8.11.1 Company Overview
  • 8.11.2 Company Snapshot
  • 8.11.3 Financial Overview
  • 8.11.4 Product Listing
  • 8.11.5 Entropy
• 8.12. MicroPort Scientific Corporation
  • 8.12.1 Company Overview
  • 8.12.2 Company Snapshot
  • 8.12.3 Financial Overview
  • 8.12.4 Product Listing
  • 8.12.5 Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us